At the TD Cowen conference, Merck executives revealed that the company's animal health business revenue is expected to more than double by the mid-2030s.

This forecast highlights Merck's strong confidence in the future development of its animal health division. As global demand for pet medical care and livestock health management continues to rise, this business segment is expected to become an important growth engine for the company. Market analysis points out that the development of innovative drugs and vaccines in the animal health sector, as well as the advancement of digital health solutions, will be key factors driving revenue growth. With its long-term technological accumulation and global market presence, Merck is expected to take a leading position in this trend.